Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VOLFI: Panitumumab plus FOLFOXIRI in RAS wild-type metastatic colorectal cancer
NCT01328171Phase 2Completed
- Sponsor
- AIO-Studien
- Start
- Apr 2011
- Primary completion
- Jun 2017
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of panitumumab in colorectal cancer (metastatic) (mCRC), sponsored by AIO-Studien. Started Apr 2011; status: completed.
02
Drugs
panitumumab
03
Conditions
colorectal cancer (metastatic) (mCRC)
Beyond the preview
Go deeper on NCT01328171.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01328171.